Astraea in the Spotlight

Novel drug candidate with a first-in-class mechanism for smoking cessation & abstinence, advancing into clinical development
 
Dr. Nurulain T. Zaveri, PhD, FAAPS, is the first recipient of inaugural 2020 Alice E. Till Recognition for Advancement of Women in Pharmaceutical Sciences, from the American Association of Pharmaceutical Sciences (AAPS).
Dr. Zaveri is a Fellow of the AAPS, and a founding leader for the Women in Pharmaceutical Sciences community at AAPS.
 

 

Copyright © 2019 by Astraea Therapeutics LLC. All rights reserved.